Cramer Dissects Disney
Health Care: Drugs
Ligand Pharmaceuticals Inc. (LGND: NASDAQ)
$14.27 0.34 | 2.44%
02/08/12 - 04:00 PM ET
61.70K / 145.90K
Vol / Avg. Vol:14.02 / 13.93
Open / Prev. Close:14.02 - 14.32
Today's Range:8.98 - 16.24
52 Wk Range:20.22%
Performance YTD:TheStreet Rating:
Portfolios with LGND
- Portfolio NameUser Type
- ProDaniel Loeb - Third Point
- ContributorStocks With Big Insider Buy...
- Contributor8 Stocks With Substantial I...
- User©SUPRATRADE HOT STOCKS (...
- ContributorBarron's Insider Purchases ...
- UserBVF Inc.
- ContributorBarron's Insider Purchases ...
- UserNorm1000 Portfolio 1
- UserBarron's Insider Purchases ...
- UserTop Short Squeeze Situations
Latest LGND Headlines from TheStreet
- Insiders Trading DDMG, FCN, CCMO 11.23.11 | 09:11 am
- 8 Stocks Rising on Unusual Volume 11.09.11 | 12:11 pm
- Ligand Stock Falls On Unusually High Volume (LGND) 11.08.11 | 01:11 pm
- Ligand Stock Hits New 52-Week High (LGND) 09.08.11 | 09:09 am
- Cramer's 'Mad Money' Recap: China Report Could Fuel Rally (Final) 09.07.11 | 07:09 pm
- 'Mad Money Lightning Round': Ligand Pharma Looks Good 09.07.11 | 07:09 pm
- 5 Stocks Flashing Insider-Buying Alerts 08.31.11 | 03:08 pm
- Insiders Trading MLI, ACGL, LGND 08.31.11 | 09:08 am
- Ligand Stock Soars (LGND) 08.29.11 | 01:08 pm
- Insiders Trading PAA, OPEN, VHI 08.22.11 | 08:08 am
Press Releases for LGND
- Ligand Reports Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.07.12 | 04:02 pm
- Ligand Names Nishan De Silva, M.D., Vice President Of Corporate Development - Business Wire 02.07.12 | 08:02 am
- Ligand Presents Full Data From Successful Phase II Trial Of Captisol-Enabled®, Propylene Glycol-Free Melphalan At The BMT Tandem Meetings - Business Wire 02.01.12 | 09:02 pm
- Ligand To Report Fourth Quarter Results On February 7 - Business Wire 02.01.12 | 12:02 pm
- Ligand To Present At The Biotech Showcase Conference On January 10th - Business Wire 01.04.12 | 05:01 pm
- Ligand Enters Into Platform Captisol® License And Supply Agreements With Lilly - Business Wire 12.21.11 | 08:12 am
- Ligand Announces Positive Preclinical Data On Small-Molecule GCSF Receptor Agonist At The 53rd Annual Meeting Of The American Society Of Hematology - Business Wire 12.12.11 | 04:12 pm
- Ligand To Present At The Oppenheimer Healthcare Conference On December 14 - Business Wire 12.07.11 | 05:12 pm
- Ligand Pharmaceuticals Announces Third Quarter Results - Business Wire 11.08.11 | 04:11 pm
- Ligand Announces Positive Preclinical Data On IRAK4 Program At The 2011 American College Of Rheumatology Annual Scientific Meeting - Business Wire 11.07.11 | 09:11 am
Partner Headlines for LGND
- Insiders And Hedge Fund Star Dan Loeb Are Bullish About These Stocks - Seeking Alpha 12.23.11 | 08:12 am
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- 10 Rallying Small-Caps Bought Up By Insiders - Seeking Alpha 09.16.11 | 04:09 pm
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.27.11 | 09:07 am
- Low-Priced Biotech Stocks With Insider Buying - Seeking Alpha 03.18.11 | 06:03 pm
- 6 Stocks With Substantial Insider Buying - Seeking Alpha 03.04.11 | 07:03 am
